Cardiorenal benefits of finerenone: protecting kidney and heart
AbstractPersons with diabetes and chronic kidney disease (CKD) have a high residual risk of developing cardiovascular (CV) complications despite treatment with renin-angiotensin system blockers and sodium-glucose cotransporter type 2 inhibitors. Overactivation of mineralocorticoid receptors plays a...
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Taylor & Francis Group
2023-12-01
|
| Colecção: | Annals of Medicine |
| Assuntos: | |
| Acesso em linha: | https://www.tandfonline.com/doi/10.1080/07853890.2023.2171110 |